Now playing Next Health news This new tool could edit DNA to cure inherited heart defects The technology works by targeting “faulty” copies of genes that cause a defect that weakens the heart muscles. 05/08/2022
Now playing Next world news Drugmaker launches lottery for life-saving gene therapy in babies Swiss drugmaker Novartis has launched an international lottery for its groundbreaking and extremely costly gene therapy Zolgensma, sparking both hope and outrage among patients’ families. 02/01/2020